Mutations in purine nucleoside phosphorylase deficiency. 1997

M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.

Purine nucleoside phosphorylase deficiency is an inherited disease of purine metabolism characterized clinically as combined immunodeficiency. The molecular defects have been published for 4 different alleles in 3 patients. We report four new mutations including two amino acid substitutions, A174P and G190V, a single codon deletion, delta I129, and a point mutation in intron 3 which leads to aberrant splicing and creation of a premature stop codon in exon 4 (286-18G-->A). Of the previously reported mutations, E89K was found in one additional patient, and R234P was found in 3 unrelated patients, making R234P the most common mutation reported to date in this disease.

UI MeSH Term Description Entries
D007438 Introns Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes. Intervening Sequences,Sequences, Intervening,Intervening Sequence,Intron,Sequence, Intervening
D008661 Metabolism, Inborn Errors Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero. Inborn Errors of Metabolism,Metabolism Errors, Inborn,Error, Inborn Metabolism,Errors Metabolism, Inborn,Errors Metabolisms, Inborn,Errors, Inborn Metabolism,Inborn Errors Metabolism,Inborn Errors Metabolisms,Inborn Metabolism Error,Inborn Metabolism Errors,Metabolism Error, Inborn,Metabolism Inborn Error,Metabolism Inborn Errors,Metabolisms, Inborn Errors
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
January 2000, Ryoikibetsu shokogun shirizu,
M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
January 1991, Immunodeficiency reviews,
M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
January 1998, Ryoikibetsu shokogun shirizu,
M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
January 2003, Nihon rinsho. Japanese journal of clinical medicine,
M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
December 1996, Nihon rinsho. Japanese journal of clinical medicine,
M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
February 1995, Pediatric neurology,
M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
March 2008, Clinical biochemistry,
M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
October 1992, American journal of human genetics,
M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
October 2004, Nucleosides, nucleotides & nucleic acids,
M L Markert, and B D Finkel, and T M McLaughlin, and T J Watson, and H R Collard, and C P McMahon, and L G Andrews, and M J Barrett, and F E Ward
April 1986, European journal of pediatrics,
Copied contents to your clipboard!